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ABSTRACT
Objective: To investigate efficacy of diclofenac compared to placebo in relieving pain on removal of indwelling 
urethral catheters. Material & method: This study was a randomized controlled trial, double blind, comparing 
diclofenac with placebo in relieving pain on removal of indwelling urethral catheters. Adult male patients with 
indwelling catheters admitted in surgical ward of RSUP Dr. Sardjito Yogyakarta who met the inclusion criteria were 
recruited. The independent variables were diclofenac or placebo treatment, while the dependent variables were visual 
analogue scale (VAS) score, and the external variables were age, education level, and duration of indwelling urethral 
catheter. We gave patients diclofenac or placebo in capsules 2 hours before urethral catheter removal. Immediately 
after removal by assistant, the patient filled VAS form. We used Chi-square test, independent T-test, and bivariate 
analysis with SPSS program version 11.5, with p<0,05 was set as statistically significant level. Results: Thirty patients 
met inclusion criteria. Mean VAS score of both groups was 33,467 + 20,4577, diclofenac group was 31,567 + 20,0934, 
and placebo group was 35,367 + 21,3412. There was no statistically significant difference of VAS score between both 
groups (p=0,844). Conclusion: Efficacy of diclofenac and placebo in relieving pain when performing urethral 
catheter removal is not significantly different.
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INTRODUCTION
According to International Association for the 
Study of Pain, pain is a sensory and emotional 
experience related to lesion or tissue damage 
1
potential.  All pain may induce uncomfortable 
sensory sensations and create emotional experience 
2
that is different from one individual to another.
Urethral catheterization was conducted to 
diagnose and manage urological disease. Several 
types and materials for producing catheter are 
available for urethral catheterization, and the 
selection of specific catheter type depends on the 
rationale of catheterization. Indications for urethral 
catheterization are varied, either for diagnosis or 
management. For diagnosis, urethral catheterization 
is performed in women to collect urine for urine 
culture examination in order to prevent skin bacteria 
contamination. If ultrasonography (USG) is not 
available, post-micturition urine residual volume can 
be determined by catheterisation. The instillation of 
contrast material for urethrocystography also requires 
the same procedure. For management, indications for 
urethral catheterization is to manage infravesicular 
obstruction, either due to prostatic enlargement, 
hematoma in the bladder, urethral stricture, and 
inflammatory process. Another indication is to 
monitor the amount of urine excreted from post-
operative patients as well as from patients who 
3
required no surgical procedure.
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OBJECTIVE
To study the efficacy of diclofenac compared to 
placebo in relieving pain during urethral catheter 
removal in patients with indwelling catheter.
If the catheterization is no longer required, the 
urethral catheter should be removed or replaced. 
During the removal, the patient will suffer from pain, 
although only transient, due to the scraping of the 
catheter on the urethral luminal wall, producing 
intense discomfort, so that some of the patients refuse 
4
to have catheter reinsertion.
Pain during the urethral catheter removal may be 
due to spontaneous or stimulated discomfort 
2
sensation, which is called as dysesthesia.  Therefore, 
to reduce or eliminate pain during urethral catheter, 
analgesics should be provided to make the patient 
comfortable.
Diclofenac is one of non-steroidal anti-
inflammatory drugs (NSAID) with analgesic (anti-
5
pain) as well as anti-inflammatory effects.  In this 
study the efficacy of diclofenac was compared to 
placebo in relieving pain during urethral catheter 
removal.
MATERIAL  &  METHOD
This study was a randomized, double blind, 
controlled trial, comparing diclofenac to placebo in 
patients with indwelling catheter. The study was 
performed in Surgical Ward, Dr Sardjito Hospital, 
Yogyakarta. Period of study was from February 2009 
until the time when the planned number of samples 
was achieved.
Study population was adult male patients with 
indwelling catheter. Available population was patients 
hospitalized at Surgical Ward, Dr. Sardjito Hospital, 
Yogyakarta, from February 2009, who met the 
inclusion criteria. The inclusion criteria were adult 
males who had first catheter insertion, agreeing to join 
the study, and status post-operative (orthopaedic, 
digestive, and urological). Exclusion criteria were 
chronic diabetes mellitus with neuropathic 
complications, neurologic deficit, post-lower urinary 
tract surgery, malignant tumor, and pelvic fracture.
Notes on postoperative orthopaedic, digestive, 
urological, tumor, and plastic surgery were found by 
observing the medical records. In addition, the 
presence of diabetic nephropathy in diabetes mellitus, 
neurological deficit, post-lower urinary tract 
operation, the presence of malignant tumor, and the 
presence of pelvic fracture were also found by 
observing the medical record of each patient.
Total sample according to hypothetical test 
formula on proportional difference by Lemeshow 
6
(1991) was 13 individuals for each group.  Level of 
pain was determined using visual analogue scale 
(VAS) score, filled by the patients after the catheter 
removal.
In this study, an assistant informed about the 
study procedures assisted the author. Patients who 
met the inclusion criteria were asked to sign informed 
consent if they agreed to join the study. The patients 
were informed about the procedure, drugs provided, 
and the effect of action of the drugs. The patients' 
name, age, education, number of medical record, 
admission date, and duration of indwelling catheter 
were recorded.
Diclofenac, in a dose of 50 mg, and lactose 
powder as placebo, were put into identical white and 
green capsules. All drugs were put into marked 
plastics bags. Only the authors knew which plastic 
bags contained active drugs or placebo. Study patients 
were given diclofenac or placebo by the assistant as 
determined by randomization. Post-operative patients 
routinely receiving analgesics, treatment was given at 
least 6 hours after the analgesic administration. 
Patients were given diclofenac or placebo, as 
randomized, 2 hours prior to catheter removal. 
Precisely two hours after the administration of either 
placebo or diclofenac, the catheter was removed by 
the assistant. The patient immediately filled in the 
available VAS sheet about the pain he felt.
The independent variable in this study was the 
administration of diclofenac or placebo, while the 
dependent variable was the score of visual analogue 
scale (VAS). Measurement scale of the variables was 
numeric. The external variables in this study were 
age, level of education, and duration of indwelling 
catheter.
26
JURI, Vol. 17.  No. 1.  January  2010: 25-30
RESULTS
Subjects were adult male patients with indwelling 
urethral catheters, treated at Surgical Ward, Sardjito 
Hospital, Yogyakarta. Total patients meeting the 
inclusion criteria and agreeing to participate in this 
study were 30 individuals, comprising 15 individuals 
in diclofenac group and 15 individuals in placebo 
group. Mean patient age was 44,87 + 18,955 years, 
with the youngest aged 18 years and the oldest 84 
years.
Level of education was classified into elementary, 
secondary (SMP, SMA) and higher (university) 
education. In placebo group, patients with elementary 
education were 3 individuals, secondary education 2, 
and higher education 4 individuals. In diclofenac 
group, those with elementary education 3 individuals, 
secondary education 10, and higher education 2. Chi-
square test analysis was performed in both groups 
according to the level of education. There was no 
statistically significant difference in level of education 
in both treatment groups (p=0,641).
Mean duration of catheter indwelling in both 
groups was 2,93 + 2,212 days, while that in placebo 
group was 3,33 + 3,039 days and in diclofenac group it 
was 2,53 + 0,743 days. Independent t-test was 
performed on duration of indwelling catheter. There 
was no statistically significant difference in both 
groups for duration of indwelling catheter (p=0,159).
From these basic data, there was no significant 
difference between diclofenac and placebo groups in 
terms of age, level of education, and duration of 
indwelling catheter. It could therefore be inferred that 
The basic characteristics of subjects, which are 
numeric scale, are reported as mean and standard 
deviation. Difference of means for numeric data, 
including basic characteristics and VAS scores 
between both groups was tested using the independent 
T-test. The value of p < 0.05 was chosen as statistical 
significance. Different proportion of nominal data in 
both groups was tested using Chi-square test. 
Bivariate analysis was performed to analyze 
relationship of VAS scores with age, level of 
education, and duration catheterisation. Statistical 
tests in this study were performed using SPSS program 
version 11.5.
Ethical agreement for this study was obtained 
from ethical committee for human biomedical 
research, Faculty of Medicine, Gadjah Mada 
University (UGM), Yogyakarta. Patients were given 
clear information on the objective and the course of 
study. After they understood and agreed to participate, 
they signed the informed consent.
Table 1. Basic data characteristics of the study subjects.
Variables Placebo Group
(N=15)
Diclofenac
Group (n=15)
p
Age (mean + SD) 41,930 + 18,387 47,80 + 19,691 0,817
Education 
- Elementary 3 3
- Secondary 8 10 0,641
- High    4                          2
Duration of indwelling catheter (mean + SD)                     3,33 + 3,039  2,53 + 0,743        
SD: Standart Deviation
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Basic characteristics examined in this study were 
age, level of education, and duration of indwelling 
catheter (Table 1). The sex of the patients was 
homogeneous, male. Mean age in the placebo group 
was 41,930 + 18,387 years and in diclofenac group 
was 47,80 + 19,691 years. Independent t-test was used 
in both groups according to age. There was no 
statistically significant difference in age of both 
treatment groups (p=0,817).
both groups were homogeneous. It has been known 
that age and education influence the perception of 
pain. Duration of indwelling catheter is also 
influential, since longer duration may lead to the 
emergence of crustae around the catheter, which 
7
causes pain during removal.  In this study, there was no 
significant difference between diclofenac and placebo 
groups in terms of the duration of indwelling catheter. 
In conclusion, the duration of indwelling catheter did 
not affect the result of the study.
VAS score evaluation was completed by the 
patient himself after catheter removal. The patient was 
asked to evaluate sensation of pain during removal 
catheter by the assistant. Percentage of mild pain 
perception in diclofenac and placebo groups were 
reported by 9 (60%) and 10 (66,67%) individuals, 
respectively, moderate pain by 6 (40%) and 4 
(26,67%) individuals, while severe pain by 1 (6,66%) 
individual in the placebo group (Table 2).
The VAS scores were then analyzed with 
independent T-test to determine the significance level, 
with the independent variable the groups receiving 
diclofenac and placebo. Mean VAS score in both 
groups were 33,467 + 20,4577. Mean VAS score in 
diclofenac group was 31,567 + 20,0934 and that in 
placebo group 35,367 + 21,3412. Pain interpretation 
both in diclofenac and placebo groups belonged to the 
criteria of mild pain (0 - 40). Mean VAS score in 
diclofenac group was lower than that of placebo group. 
However, statistically significant difference in both 
groups were not found in terms of VAS score 
(p=0,844). 
Pain Perception
Diclofenac Placebo
N % N %
Table 2. Percentage of pain perception in each group.
Mild 9 60 10 66,67
Moderate 6 40 4 26,67
Severte 0 0 1 6,66
Placebo group 35,367 + 21,3412 Mild
Diclofenac group 31,567 + 20,0934 Mild
Variables Mean Score Pain 
Perception 
p 
value
0,844
Table 3. Result of VAS scores for pain in each group.
Bivariate analysis was performed on VAS scores 
in diclofenac groups according to age, and the result 
was -0,622 with p=0,013. This indicates that, in 
diclofenac group the older the patient's age the lower 
the VAS score. In placebo group, the p value was 
0,937, indicating no significant relationship between 
VAS score value in placebo group according to age.
Bivariate analysis was also performed on 
difference of VAS score in diclofenac group according 
to the duration of indwelling catheter, and the result 
was found to be not significant (p=0,985). The same 
finding was also found in placebo group, where there 
was no significant difference between VAS score 
according to the duration of indwelling catheter 
(p=0,449).
The difference of VAS score in diclofenac groups 
in terms of level of education was also subjected to 
bivariate analysis, and there was no significant 
difference (p=0,198). In placebo group, there was no 
significant difference in VAS score in terms of level of 
education (p=0,911).
DISCUSSION
Sex has influence on pain perception because it 
8
is included in biological variation.  Subjects enrolled 
in this study were all male. This was intended to 
obtain homogeneous population in this study. In 
addition, males were selected as subjects in this study 
because the urethra is longer than that in female, 15-
25 cm in male and 3-5 cm (averagely 4 cm) in female. 
Length of urethra may affect the induced pain during 
removal of catheter. Since male's urethra is longer, 
pain episodes during urethral catheter removal takes 
a longer time. It was expected that males in this study 
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were able to describe their pain perception during 
urethral catheter removal more clearly than the female 
4
patients whose urethra were shorter.
Age also affects the perception of pain. In this 
study, mean patient age in both groups was 44,87 + 
18,955 years. Mean age in placebo group was 41,930 + 
18,387 and that in diclofenac group was 47,80 + 
19,691 years. Age variation in both groups did not 
show significant difference (p=0,817; IK 95%). This 
was consistent with the findings of Kertia & 
Nurdjanah (2006), that the influence of age on pain 
1
intensity was not statistically significant.  In that study, 
the mean age in experimental group was 65,94 + 8,29 
and in control group 63,95 + 7,41, with p=0,451. A 
study by Maulana (2007) also showed similar 
findings, with mean age of placebo group 41,930 + 
18,387 years, and in diclofenac group 47,80 + 19,691 
4
years (p=0,817).
Bivariate analysis on the difference in VAS scores 
according to age in diclofenac group after treatment 
showed negative correlation (-0,622), where older 
patients had lower VAS scores (p=0,013). Placebo 
group showed no significant difference between VAS 
score in terms of age (p=0,937). It is plausible that in 
9
older individuals, sensory systems are less sensitive.  
Pain is a sensation transmitted by sensory nerve 
through spinal cord to the brain sensory area, and the 
sensation will be received. Nociceptive pain occurs 
from the activation of free nerve endings of sensory 
nerve fibers and the viscera. In elderly, sensory and 
visceral sensation decreases, which sometimes results 
7
in general hypoesthesia.
Level of education may also affect pain 
7
perception.  The higher the level of education, the 
lower the pain perception. In this study, levels of 
education were grouped into elementary, secondary 
(SMP-SMA), and high education (university). In both 
groups, most patients had secondary school education 
(18 individuals), followed with elementary education 
(6 individuals), and higher education (6 individuals). 
Chi-square analysis revealed that the proportion of the 
patients' level of education in both groups was not 
significantly different (p=0,641). Then, bivariate 
analysis was undertaken on the difference between 
VAS scores in both groups related to age, from which 
no significant difference was found, either in 
diclofenac group (p=0,198) and placebo (p=0,911). 
This demonstrates that patients' level of education 
does not affect pain perception in both treatment 
groups. The result was similar to Kertia and 
1,4
Nurdjanah (2006) and Maulana (2007).
Mean duration of indwelling catheter in both 
groups was 2,93 + 2,212 days, while that in diclofenac 
group was 2,53 + 0,743 days and in placebo group 
3,33 + 3,039 days. In both groups, the shortest 
duration of indwelling catheter was 2 days (17 
patients) and the longest 14 days (1 patient). Chi-
square analysis was performed on the basic data on 
indwelling catheter, revealing no significant 
difference in the proportion of indwelling catheter in 
both groups (p=0,159). Using independent t-test, we 
analyzed the difference of VAS score in both groups 
according to the duration of indwelling catheter. In 
this study there was no significant difference in VAS 
score in terms of the duration of indwelling catheter, 
both in diclofenac (p=0,985) and placebo (p=0,449) 
groups. Pain is a signal of tissue irritation, a 
forthcoming injury or an undergoing injury. Sensory 
nerve fibers (nociceptor) in affected area become 
activated and transmit signals through peripheral 
nerve and spinal cord to the brain. Activated spinal 
reflex complex is followed by perception, cognitive 
and effective response, and possibly a deliberate 
movement. Lengthy duration of catheter may induce 
urethral mucosa injury and induce crustae 
surrounding the urethra. The removal of this catheter 
7
may induce higher pain stimulus.
This study found that the mean VAS score in both 
groups was 36,96, while VAS score in diclofenac 
group was 31,567 + 20,0934 and in placebo group was 
35,367 + 21,3412. These results showed that average 
patients in both groups only complained of mild pain 
during catheter removal, particularly in placebo 
group.
The difference of VAS score in both groups did 
not show statistical significance (p=0,844). This 
indicates that reduction of pain by diclofenac was not 
statistically significant compared to placebo.
Mild pain perceived by patients in diclofenac 
group may possibly be affected also by psychological 
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CONCLUSION
The efficacy of diclofenac is not significantly 
different from that of placebo in relieving pain during 
urethral catheter removal.
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condition of the patients. Patients experienced 
psychosomatic pain due to the fear of catheter 
removal, not due to catheter irritation to the urethra. 
Fear, stress, anxiety, pain and other psychological 
11
factors may influence pain perception.  Before 
catheter removal, the patient should be informed that 
the procedure will not induce pain, because it is 
undertaken in a correct manner. Therefore, 
communication to the patient is important prior to 
removal of urethral catheter.
Another possible cause of pain in diclofenac 
group was the time of administration. In this study, 
treatment was given 120 minutes after diclofenac 
administration, and afterwards the concentration 
decreased fast. Diclofenac's half-life was 1-3 hours, 
with peak concentrations in 2 hours. However, other 
literature mentions a half-life of diclofenac 0,33 - 2 
hours, with peak concentrations reached in 1 hour. 
Therefore, it was possible that during VAS score 
assessment, diclofenac concentration was starting to 
decrease.
In addition, short time of study (2,5) and small 
number of samples (30 individuals) also influenced 
lack of significance of diclofenac in reducing pain 
compared to placebo. Sample was determined from 
the assumption that patients who did not feel pain 
during urethral catheter removal, those with 
diclofenac were 70% and placebo 20%. In this study, 
there was no patient who did not experience pain at all 
by receiving diclofenac. However, in both groups 
there were two patients each with VAS scores less than 
1. Since the mechanism of acute pain is multifactorial, 
psychological factor may also play a role. In addition 
to the provision of analgesics, good communication 
may also help relieve pain.
30
JURI, Vol. 17.  No. 1.  January  2010: 25-30
